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A B S T R A C T
With hydrophilic surface and high surface area, porous silica has been applied to load in-
soluble drugs. Compared to solvent equilibrium method, resveratrol (RES)–mesoporous silica
microparticles (MSM) solid dispersion prepared by fluid bed demonstrated higher drug loading
and more complete dissolution. Pore volume and diameter have more remarkable effects
than surface area to the drug loading and in vitro dissolution profiles. RES–polyethylene glycol
solid dispersion with high drug loading showed fast but incomplete dissolution due to the
recrystallization. The combination of fluid bed and MSM was an effective strategy to improve
drug loading as well as dissolution for poorly water-soluble drugs.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Shenyang Phar-
maceutical University. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
With the development of high throughput screening (HTS) from
the 1980s, combinatory chemistry and HTS discovered numer-
ous poorly water-soluble new chemical entities (NCEs) as drug
candidates [1]. Studies have demonstrated that oral immedi-
ate release (IR) drug products constituted more than 50% of
the top 200 drug product lists from four developed countries.
More than 40% of these products on each list were deter-
mined to be poorly water-soluble drugs, and among them more
than 30% belong to the Biopharmaceutics Classification System
(BCS) II class with good membrane permeability but poor
aqueous solubility [2].
In order to solve the dissolution problem of poorly water-
soluble drugs, solid dispersion technology with polymers
prepared by solvent evaporation method [3], supercritical fluid
method [4], spray drying [5], hot-melt extrusion [6], and spray
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freeze drying (SFD) [7] have been extensively investigated. The
interaction between drug molecule and carrier may retard drug
recrystallization from the solid dispersion system and lead to
quick dissolution [8]. The most popular carrier materials used
in the solid dispersion are water-soluble polymers (e.g. PEG and
PVP), which tend to be hygroscopic or sticky and which result
in a reduction in the recovery of the solid dispersion and bring
difficulty in the subsequent manufacture processing. More-
over, as milling or mixing with other excipients is often
conducted before encapsulated into capsules or tableting, this
sometimes facilitates crystallization of drug from the solid dis-
persion with the reduced dissolution.
In consideration of the disadvantages of solid dispersion with
a water-soluble polymer, solid dispersion with porous mate-
rials such as silica, carbon nanotube [9], ZnO [10], starch [11]
and magnesium carbonate [12] have been developed since 2004.
Among these materials, porous silica has received wide at-
tention particularly since silanol groups on the surface may
be able to form hydrogen bonds with drug molecules, which
results in a decrease in the crystallinity of drugs [13–17]. The
differences between solid dispersions with hydrophilic and hy-
drophobic silica [8], porous and nonporous silica [13], different
porous properties silica [18] or manufacturing by different
methods [19] have all been thoroughly investigated before and
will not be discussed in detail. In order to prepare a solid dis-
persion with spherical porous silicate, an approach with the
help of a Wurster-type fluid bed was published in 2014 [20].
This approach is able to manufacture drug product with a pel-
letized shape and excellent mobility that is easy to operate in
the subsequent pharmaceutical processes (e.g. encapsula-
tion or tableting). It is also easily to adjust the amount of the
drug loading by changing the amount of the feeding solu-
tion, which will provide drug products to meet different
demands in the market.Therefore, this approach may have good
potential to be widely used in solid dispersion product
development.
The fluid bed technology is mainly applied on coating and
granulation processes. For example, the fluid bed coating tech-
nology was first introduced to manufacture solid dispersion
in 2008, in which PVP and nonpareil pellets were used as car-
riers to load drugs [21–23]. As shown in the graphic abstract,
drugs/excipient to be coated into the pellets or MSNs are dis-
solved and sprayed via the nozzle. The drug may enter into the
pore channels or adsorb onto the surface of the particles, which
will mainly depend on the interaction of the drug with the
mesoporous particles and the amount/concentration of the
feeding solution.
Resveratrol (RES), a polyphenol with many biological ac-
tivities such as anti-tumor, immune-regulation and anti-
aging activities, was chosen as a model drug in this study. It
was reported to have a poor solubility and high ability to per-
meate through the enterocytes [24], and belongs to the BCS II
classification system, where the poor aqueous solubility and
dissolution affect its clinical application. The aim of this study
was to develop high drug-loaded solid dispersion of RES with
different mesoporous silica microparticles (MSM) by fluid bed
to improve its dissolution profile. Specifically, the effects of the
three kinds of MSM on drug loading and the dissolution rate
of the solid dispersions prepared by fluid bed were firstly in-
vestigated. Moreover, RES–MSM solid dispersions and RES–PEG
solid dispersion were prepared by solvent equilibrium method
for comparison. Characterization of these solid dispersions
included surface morphology, in vitro dissolution profile, solid
state forms of RES, thermal analysis and surface area
analysis.
2. Materials and methods
2.1. Materials
RES (purity ≥ 98%, Xian Caocuixin Biological Science and Tech-
nology Co. Ltd., China) was used as the model drug. MSM
(CHROMATOREX, Fuji Silysia Chemical Co. Ltd., Japan), which
is a mesoporous silica microparticle, was selected as a porous
material to load RES. Acetone and ethanol (AR, Tianjin Zhiyuan
Chemical Co. Ltd., China) were used as organic solvents to dis-
solve RES in the preparation process of solid dispersions. PEG
6000 was purchased from Shanghai Aladdin Industrial Co. Ltd.,
China.
2.2. Instruments
Mini-Glatt fluid bed (Glatt GmbH, Germany) with a 0.5 mm
nozzle and two air compressors (SF4FF, Atlas Copco) was used
to manufacture RES solid dispersion, and the RES solution on
a magnetic stirrer (PC-420, Corning) was pump into the fluid
bed by a peristaltic pump (1003, Flocon) with a rubber tube
(0.8 mm inner diameter) in the process. Agilent 1200 HPLC-
DAD (Agilent, USA) with an Eclipse XDB-C18 HPLC column
(150 mm × 4.6 mm, 5 μm, Agilent) was applied to the quanti-
tative analysis of RES. The dissolution study was performed by
dissolution-tester 700 (Erweka, Germany).
2.3. Preparation of RES–MSM solid dispersions by solvent
equilibrium method
RES was dissolved in ethanol or acetone solvent, and then the
MSM was added to the drug solution system. The RES–MSM
suspension system reached adsorption equilibrium after stir-
ring on a magnetic stirring apparatus at a low agitation speed
for a period of time. Finally, the suspension was filtered and
dried in vacuum drier at 40 °C for 24 h to reduce the residual
solvent [19]. Samples were stored in a silica-gel drier for the
following characterization.
2.4. Preparation of RES–MSM solid dispersions by fluid
bed method
MSM of 50 cm3 was placed in fluid bed first, while RES acetone
solution of 100 mg/ml was applied as the feeding solution with
the help of peristaltic pump. The process parameters of fluid
bed were set as the following: inlet air temperature: 25–30 °C;
material temperature: 22–26 °C; spray speed: 0.25–1.0 mg/ml;
supply air rate: 0.10–0.25 bar; and atomization pressure:
0.15–0.30 bar.
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2.5. Characterization of MSM and RES–MSM solid
dispersions
2.5.1. Transmission electron microscopy (TEM)
Fragments of MSM were suspended in ethanol by sonicating
for 2–5 minutes and then placed on the surface of a lacey
support film (Φ3mm), and the excess liquid was evaporated to
dryness later. Transmission electron microscopy (TEM) graphs
were obtained with a camera (Gatan 832) using a transmis-
sion electronic microscope (JEM 2100F, JEOL, Japan) operated
at 200 kV.
2.5.2. Differential scanning calorimetry (DSC)
The phase transition of RES and its solid dispersions were ana-
lyzed by differential scanning calorimetry (DSC-60A, SHIMADZU,
Japan) at a heating rate of 10 °C/min from 50 °C to 300 °C. This
procedure was operated under a nitrogen atmosphere with a
40 ml/min flow rate. Accurately weighed samples (~1.5–2.0 mg)
were placed in sealed pin-holed aluminum pans and Al2O3 was
used as a reference.
2.5.3. Powder X-ray diffraction (PXRD)
Selected samples were gently packed into sample holders. PXRD
patterns of the samples were determined by a Philips powder
X-ray diffraction system, Model PW 1830, equipped with a 3
kW Cu anode (λ = 1.54056 Å) over a 2θ interval of 3.0° to 45.0°.
The step size was 0.02°/s, with a counting time of 2 s.
2.5.4. BET surface area analysis
Specific surface area was determined with the help of nitro-
gen adsorption measurements using surface area analyzer (Flow
Sorb III 2310, Micromeritics, USA). Samples were placed in
helium at 40 °C for 6 h before analysis.
2.5.5. Dissolution studies
Using Milli-Q water as medium, dissolution study was per-
formed by dissolution-tester 700 (Erweka, Germany) at 37 ± 0.5 °C
with the paddle speed at 50 rpm. RES of 10 mg or physical
mixture (PM) with 10 mg RES and 90 mg MSM, or solid disper-
sions with 10 mg RES and different amount of MSM/PEG, were
added into 900 ml of dissolution media, respectively. Samples
of 5 ml were withdrawn at predetermined time intervals, and
an equal volume of the dissolution medium was added to main-
tain the volume constant after each withdrawal. The content
of dissolved RES was determined by HPLC (Agilent, USA). All
of the dissolution experiments were performed in triplicate.
2.5.6. HPLC analysis
HPLC analysis of RES was conducted at an Agilent 1200 series
HPLC system (Santa Clara, USA) equipped with an Agilent
Eclipse XDB-C18 column (150 mm × 4.6 mm, 5 μm) and a pho-
todiode array detector was employed. Mobile phase, composed
of acetonitrile and water (27:73, v/v), was eluted at 1.0 ml/min.
Ten-microliter samples were injected. A calibration curve based
on the area ratio of the RES (0.99–99.90 μg/ml) at 306.0 nm ex-
hibited excellent linearity (R2 > 0.9999). The RSDs of intra- and
inter-day precision and accuracy for RES at three different con-
centrations (74.93, 24.98, 4.99 μg/ml) were less than 3.0% (n = 5).
3. Results and discussion
3.1. Characteristics of the blank MSM
In order to study the relation between the quality of RES–
MSM solid dispersions and the porosity properties of MSM, three
different types of MSM with similar particle size were used.
As shown in Fig. 1A and B, MSM has a uniform size between
50 and 100 μm. The TEM graph of MSM fragment (Fig. 1C and
D) revealed that MSM was stacked by nanoparticles, which may
have strong covalent bond with each other to guarantee the
structure stability of the pelletized MSM where the pore channel
was the inter-particle porosity. As shown in Fig. 2A, PXRD dem-
onstrated that MSM is in an amorphous state without intensive
crystal diffraction peaks. Moreover, similar to SEM, OM, TEM
and PXRD graphs were observed for the selected three types
of MSM (data not shown). BET surface area analysis con-
firmed the result that porous silica had a type IV adsorption–
desorption isotherm to N2, water and organic vapor [25], which
feature in capillary condensation and stranded loopback
(Fig. 2B). Moreover, analysis clarified that the pore volume of
MSM amplifies with the increase of its pore diameter, while
the surface area is negatively related to pore volume and pore
diameter (Table 1). Large surface areas and pore volumes of
MSMs are able to load more drugs. The pore diameters were
distributed between 2.5 and 13.8 nm, while molecular size of
RES molecule was 1.181 nm by the calculation of GAUSSIAN
03. Therefore, it is expected that RES could be loaded in the
pore channel of the MSM.
3.2. Effect of drug loading on dissolution of the solid
dispersion and MSM property prepared by fluid bed
To prepare different drug-loaded solid dispersions by fluid bed,
different volume of feeding solution was sprayed onto the
porous silica. The dissolution profiles and PXRD characteriza-
tion results of three batches of RES-MB5D solid dispersions with
different drug loading are shown in Figs. 3 and 4A. It was dem-
onstrated that drug loading of solid dispersion was negatively
related with the dissolution rate. However, over 80% RES was
released from all the formulations within 2 h. From PXRD results
(Fig. 4A), crystalline drug increasingly appeared along with the
increased drug loading in the prepared solid dispersions.
To further investigate the effect of drug loading on the prop-
erty of MSM, BET surface area test was applied to SD2 and SD3,
which has a drug loading of 22.2% ± 1.9% and 33.7% ± 0.7%, re-
spectively. As shown in Table 1, the pore volume and specific
surface area of MB5D decreased after loading drug, whereas
the pore diameter remained the same. In addition, solid dis-
persion with high drug loading (i.e. SD3) results in the reduced
pore volume and specific surface area.
3.3. Effect of MSM on drug loading onto solid dispersion
prepared by fluid bed
Nagane et al. (2014) have demonstrated that the larger the spe-
cific surface area, the more amorphous drug could be loaded
on MSM with similar particle sizes [20]. The author further ex-
plained that the larger specific surface area renders that a large
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Fig. 1 – SEM (A), OM (B) and TEM (C/D) graphs of mesoporous silica microparticles.
Fig. 2 – PXRD spectrogram (A) and N2 adsorption–desorption isotherms (B) of MSM.
Table 1 – Porosity properties of MSM and RES solid dispersions.
Category Surface area (m2/g) Pore volume (ml/g) Mesopore diameter (nm) Particle size (D50/µm) Drug loading
MB3A 727 0.45 2.45 103.9 –
MB4B 549 0.84 6.13 107.6 –
MB5D 350 1.21 13.8 91.23 –
SE1a 221 0.86 15.5 – 14.0% ± 0.9%
SD2a 222 0.82 14.7 – 22.2% ± 1.9%
SD3a 127 0.52 16.2 – 33.7% ± 0.7%
a SE1 was prepared by solvent equilibrium method with MB5D. SD2 and SD3 were manufactured by fluid-bed method.
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amount of silanol groups could interact with drugs via hydro-
gen bonding, hence more amorphous drug to be loaded. In the
present study, the effects of MSM property on the loadable
amount of amorphous RES on solid dispersions by fluid bed
were also studied. Three kinds of MSMs with different porous
property were used to prepare RES solid dispersion with dif-
ferent drug loading. As shown in Fig. 4A, RES in the solid
dispersion existed in amorphous form until the drug loading
was over 30% when MB5D with the largest pore volume and
surface area was used. In addition, PXRD profiles in Fig. 4B and
C showed that RES was crystalized when the drug loading was
around 20% or 10% in the RES-MB4B or RES-MB3A solid dis-
persion, respectively.Therefore, with the increased drug loading,
RES is likely to be recrystallized from the solid dispersion, and
intensive characteristic peaks of RES could be gradually ob-
served on PXRD profiles. Moreover, there is a trend that solid
dispersions with large pore volume of MSM have higher drug
loading as the amorphous form. Based on these results, we pro-
posed that pore volume and mesoporous diameter also affect
the amorphous state of RES besides the surface area. Since at-
omization and drying of droplet were simultaneously processed
in fluid bed, smaller pore size and pore volume led to larger
ratio of droplet on the surface. The limited loadable amount
of amorphous state RES may be due to its weak hydrogen
bonding with silanol group.Therefore, pore volume has a greater
effect to loadable amount of amorphous RES than specific
surface area.
Fig. 3 – Dissolution profiles of RES solid dispersions with
MB5D at different drug loading (n = 3).
Fig. 4 – PXRD profiles of solid dispersions prepared with three types of MSM.
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3.4. Effect of MSM on drug dissolution from the solid
dispersions prepared by fluid bed
Except the effect of pore volume of MSM on amorphous drug
loading on solid dispersion, we also notice that the reduced
pore volume and pore diameter could slow down the dissolution
rate and decrease the accumulative dissolution of RES solid
dispersions shown in Fig. 5. Three kinds of MSMs were used
to load RES to 10% approximately, in which RES-MB5D solid
dispersion with the largest pore volume and pore diameter
demonstrated the fastest dissolution rate, followed by RES-
MB4B and RES-MB3A. Small pore volume and pore diameter
of MSM may lead to more recrystallized drug at the surface
of the MSM with poor dissolution behavior, which may also
hinder fast dissolution of the amorphous drugs in the pore of
the MSM.
3.5. Comparison of solid dispersions prepared by two
methods
Despite using MSM with the largest (i.e. MB5D) or smallest pore
diameter (i.e. MB3A) to prepare ~10% drug-loaded solid dis-
persions by solvent equilibrium method or fluid bed method,
the f2 similarity factor of their dissolution profiles is similar
to 50, suggesting that their dissolution profiles are quite similar
(dissolution profiles of solid dispersions made by MB5D are
shown in Fig. 6A). Table 1 and Fig. 6C showed the porosity prop-
erties of solid dispersions (SE1 was prepared with MB5D by
solvent equilibrium method, while SD2 was prepared by fluid
bed method) manufactured by two methods; SD2 and SE1 had
Fig. 5 – Dissolution profiles of RES solid dispersions with
different MSM (n = 3).
Fig. 6 – Dissolution profiles (A/B) and N2 adsorption–desorption isotherms (C) of solid dispersions prepared by two methods.
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similar porosity properties, such as pore volume, specific surface
area and N2 adsorption–desorption isotherms. The similar po-
rosity properties of SD2 and SE1 also exhibited similar drug
loading into the pore of the carrier, but SD2 had a higher drug
loading than SE1. Therefore, the above results indicated that
fluid bed method was able to coat more drugs at the surface
of MSM, and solvent equilibrium method allowed more guest
molecules to penetrate into the pore channels of MSM with
long time equilibrium.
Although solvent equilibrium method had lower drug
loading, more drugs could be loaded into the pore channel of
MSM in amorphous form.
On the contrary, fluid bed method was suitable to prepare
RES–MSM solid dispersion with a higher drug loading. Solid dis-
persion with MSM manufactured by solvent equilibrium method
has a threshold of amorphous drug loading (about 10–15%) due
to the limitation of low bonding force between MSM and RES.
In consequence, a new method, namely solvent evaporation
method [19], was applied to prepare RES–MSM solid disper-
sion with a higher drug loading. In this method, the solvent
was evaporated under gentle stirring in the open containers
for 12 h rather than filtrated in the solvent equilibrium method.
The dissolution profiles of RES-MB5D solid dispersions with
~30% drug loadings manufactured by the solvent evapora-
tion method and fluid bed method are shown in Fig. 6B.
Different from dissolution profiles in Fig. 6A, these two samples
have quite different dissolution profiles. They had similar dis-
solution rate at the beginning, but the sample by fluid bed
exhibited more complete dissolution after 2 h than other
samples.
3.6. Difference between conventional solid dispersions
with PEG and solid dispersions with MSM
Fig. 7A showed the dissolution profiles of RES solid disper-
sions with MSM and PEG 6000. The drug loading of SD1 and
SP1 was about 10%, while SD2 and SP2 was about 20%. SP1 and
SP2 with PEG 6000 were manufactured by solvent evapora-
tion method, while SD2 and SD3 were prepared by fluid bed
method. Fig. 7 revealed that solid dispersion with MSM had a
slower dissolution rate but more complete dissolution than solid
dispersion with PEG. With the increase of drug loading, solid
dispersion with MSM showed slower dissolution rate but similar
accumulative dissolution rate in 2 hours, while two solid dis-
persions with PEG showed similar dissolution rate but less
accumulative dissolution rate. As shown in Fig. 7B, the reason
for less release of solid dispersion with PEG may be the still
crystal state of RES in RES–PEG solid dispersion. However, RES–
PEG solid dispersion had a quicker dissolution rate due to PEG’s
strong hydrophilicity. Therefore, RES solid dispersion with PEG
at high drug loading had quicker dissolution rate at the first
stage, but RES solid dispersion with MSM had more complete
release.
4. Conclusions
By combination of solid dispersion technique with spherical
porous silica and fluid bed approach, solid dispersion loaded
with relatively high resveratrol with complete in vitro disso-
lution has been successfully prepared. As a drug dispersion
agent and carriers, MSM could prevent the drug from recrys-
tallization by loading the drug into its pore channel and/or on
the surface. Nevertheless, RES solid dispersions with PEG
showed incomplete dissolution as the result of recrystalliza-
tion. Moreover, results showed that the pore volume and pore
diameter of the MSM have more remarkable effects than spe-
cific surface area to the drug loading and in vitro dissolution
profiles.
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